These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical characteristics, bacterial coinfections and outcomes in COVID-19-associated pulmonary aspergillosis in a third-level Mexican hospital during the COVID-19 pre-vaccination era. Hernández-Silva G; Corzo-León DE; Becerril-Vargas E; Peralta-Prado AB; Odalis RG; Morales-Villarreal F; Ríos-Ayala MA; Alonso TG; Agustín FD; Ramón AF; Hugo AV Mycoses; 2024 Jan; 67(1):e13693. PubMed ID: 38214372 [TBL] [Abstract][Full Text] [Related]
3. Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient. Blaize M; Mayaux J; Nabet C; Lampros A; Marcelin AG; Thellier M; Piarroux R; Demoule A; Fekkar A Emerg Infect Dis; 2020 Jul; 26(7):1636-1637. PubMed ID: 32343223 [TBL] [Abstract][Full Text] [Related]
4. [Fever and inhabited pulmonary cavity in an AIDS patient]. Aguirre A; Lozano F; Gutiérrez MJ; León E; Corzo JE; Gómez-Mateos J; Martín E Enferm Infecc Microbiol Clin; 1996 Dec; 14(10):621-2. PubMed ID: 9053006 [No Abstract] [Full Text] [Related]
5. The Challenge of Managing COVID-19 Associated Pulmonary Aspergillosis. Brüggemann RJ; van de Veerdonk FL; Verweij PE Clin Infect Dis; 2021 Dec; 73(11):e3615-e3616. PubMed ID: 32810202 [No Abstract] [Full Text] [Related]
6. Fungal Infection during COVID-19: Does Fekkar A; Poignon C; Blaize M; Lampros A Am J Respir Crit Care Med; 2020 Sep; 202(6):902-903. PubMed ID: 32687389 [No Abstract] [Full Text] [Related]
7. COVID-19-Associated Pulmonary Aspergillosis in the Critical Care Setting. Livermore JM AACN Adv Crit Care; 2021 Dec; 32(4):398-403. PubMed ID: 34879133 [TBL] [Abstract][Full Text] [Related]
8. COVID-Associated Pulmonary Aspergillosis in the United States: Is It Rare or Have We Missed the Diagnosis? Zhang SX; Balada-Llasat JM; Pancholi P; Sullivan KV; Riedel S; J Clin Microbiol; 2021 Sep; 59(10):e0113521. PubMed ID: 34288730 [No Abstract] [Full Text] [Related]
9. Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis. Lamoth F; Lewis RE; Walsh TJ; Kontoyiannis DP J Infect Dis; 2021 Nov; 224(10):1631-1640. PubMed ID: 33770176 [TBL] [Abstract][Full Text] [Related]
10. The Role of Bacterial and Fungal Superinfection in Critical COVID-19. Seitz T; Holbik J; Grieb A; Karolyi M; Hind J; Gibas G; Neuhold S; Zoufaly A; Wenisch C Viruses; 2022 Dec; 14(12):. PubMed ID: 36560789 [TBL] [Abstract][Full Text] [Related]
11. Aspergillus niger pneumonia as superinfection in a patient with pulmonary tuberculosis. Ewig S; Gatermann S; Phillipou S; Giesa C; Hecker E Pneumologie; 2023 Sep; 77(9):639-644. PubMed ID: 38452864 [TBL] [Abstract][Full Text] [Related]
12. Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians. Lamoth F Curr Opin Infect Dis; 2022 Apr; 35(2):163-169. PubMed ID: 34980831 [TBL] [Abstract][Full Text] [Related]
13. Invasive pulmonary aspergillosis in patients with acute respiratory syndrome by COVID-19. Sánchez Martín C; Madrid Martínez E; González Pellicer R; Armero Ibáñez R; Martínez González E; Llau Pitarch JV Rev Esp Anestesiol Reanim (Engl Ed); 2022 Jan; 69(1):48-53. PubMed ID: 35033481 [TBL] [Abstract][Full Text] [Related]
15. Early recognition of a superinfection: This is the problem in the critically ill COVID-19 patients. Alessandri F; d'Ettorre G; Ciccozzi M; Migliara G; Baccolini V; Pugliese F; Ceccarelli G J Med Virol; 2024 Jan; 96(1):e29345. PubMed ID: 38148715 [No Abstract] [Full Text] [Related]
16. COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave. Bretagne S; Sitbon K; Botterel F; Dellière S; Letscher-Bru V; Chouaki T; Bellanger AP; Bonnal C; Fekkar A; Persat F; Costa D; Bourgeois N; Dalle F; Lussac-Sorton F; Paugam A; Cassaing S; Hasseine L; Huguenin A; Guennouni N; Mazars E; Le Gal S; Sasso M; Brun S; Cadot L; Cassagne C; Cateau E; Gangneux JP; Moniot M; Roux AL; Tournus C; Desbois-Nogard N; Le Coustumier A; Moquet O; Alanio A; Dromer F; Microbiol Spectr; 2021 Oct; 9(2):e0113821. PubMed ID: 34668768 [TBL] [Abstract][Full Text] [Related]
17. A rare case report of tracheobronchial aspergillosis with endobronchial aspergilloma in a patient clinically recovered from COVID-19. Rai DK; Kumar S Indian J Pathol Microbiol; 2022; 65(3):713-715. PubMed ID: 35900511 [TBL] [Abstract][Full Text] [Related]
18. Overtreating or underdiagnosing invasive pulmonary aspergillosis (IPA) in critically ill H1N1 patients: who is right? Martin-Loeches I; Valles J Intensive Care Med; 2012 Nov; 38(11):1733-5. PubMed ID: 22895827 [No Abstract] [Full Text] [Related]
19. Dysregulated pulmonary inflammatory responses exacerbate the outcome of secondary aspergillosis following influenza. Lee CK; Oliveira LVN; Akalin A; Specht CA; Lourenco D; Gomez CL; Ramirez-Ortiz ZG; Wang JP; Levitz SM mBio; 2023 Oct; 14(5):e0163323. PubMed ID: 37681974 [TBL] [Abstract][Full Text] [Related]
20. COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City. Jiang Z; Chen S; Zhu Q; Xiao Y; Qu J J Infect Public Health; 2022 Feb; 15(2):222-227. PubMed ID: 35032951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]